Jacek C Szepietowski
Overview
Explore the profile of Jacek C Szepietowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
466
Citations
5162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Dalen S, Stein J, Bruurmijn T, Foster M, Chirivi R, van der Linden M, et al.
Int J Dermatol
. 2025 Mar;
PMID: 40083018
Background: Neutrophils are scarce in healthy skin but infiltrate lesions of hidradenitis suppurativa (HS) patients. Activated neutrophils release proinflammatory neutrophil extracellular traps (NETs), which have been implicated in the pathophysiology...
2.
Jankowska K, Kokoszka J, Szepietowski J
Acta Derm Venereol
. 2025 Mar;
105:adv43059.
PMID: 40077980
No abstract available.
3.
Bien B, Krajewski P, Szepietowski J
Dermatol Ther (Heidelb)
. 2025 Mar;
PMID: 40050518
Introduction: Psoriasis is a chronic inflammatory skin disease affecting over 60 million people worldwide, often linked to comorbidities such as psoriatic arthritis and cardiovascular disease. Beyond physical symptoms, psoriasis can...
4.
Jaworek A, Halubiec P, Wojas-Pelc A, Szepietowski J
J Fungi (Basel)
. 2025 Feb;
11(2).
PMID: 39997425
Onychomycosis is a fungal nail infection which has a considerable impact on the quality of life of patients. The aim of this study was to analyze onychomycosis cases with respect...
5.
Mazgaj J, Kotewicz M, Jaworek A, Szepietowski J
Expert Opin Pharmacother
. 2025 Feb;
:1-8.
PMID: 39924470
Introduction: Atopic dermatitis (AD) is a chronic inflammatory skin condition, rising in prevalence and significantly impacting quality of life. Janus kinase (JAK) inhibitors are small molecules targeting the JAK-STAT signaling...
6.
7.
Verma S, Khurana A, Bosshard P, Kargl A, Singal A, Saraswat A, et al.
Indian J Dermatol Venereol Leprol
. 2025 Feb;
91(2):277-280.
PMID: 39912159
No abstract available.
8.
Ficheux A, Ficheux A, Brenaut E, Brenaut E, Schut C, Schut C, et al.
J Am Acad Dermatol
. 2025 Jan;
PMID: 39884581
Background: Anxiety, depression and suicidal ideation are frequent in patients with chronic prurigo (CPG). Objective: To analyze perceived stress, stigmatization, body dysmorphia, anxiety, depression and itch-related quality of life in...
9.
Chernyshov P, Finlay A, Tomas-Aragones L, Poot F, Murrell D, Pustisek N, et al.
Int J Dermatol
. 2025 Jan;
PMID: 39878243
In this paper, the European Academy of Dermatology and Venereology (EADV) Task Force on Quality of Life (QoL) and Patient-Oriented Outcomes presents its position statements on health-related (HR) QoL assessment...
10.
Putek J, Szepietowski J
Postepy Dermatol Alergol
. 2025 Jan;
41(6):584-589.
PMID: 39877109
Introduction: Tattoos are a form of body modifications. Alexithymia is a complex personality structure that includes emotional and cognitive deficits such as difficulty in recognizing and describing feelings. Aim: To...